OW
ABBV icon

Olistico Wealth’s AbbVie ABBV Stock Holding History

Olistico Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Buy
1,884
+925
+96% +$199K 0.2% 70
2026
Q1 		$209K Buy
959
+132
+16% +$29.3K 0.1% 97
2025
Q4 		$189K Buy
+827
New +$188K 0.09% 96
2025
Q3 		– Sell
-849
Closed -$158K – 97
2025
Q2 		$158K Buy
849
+53
+7% +$9.85K 0.09% 105
2025
Q1 		$167K Sell
796
-1
-0.1% -$194 0.1% 107
2024
Q4 		$142K Buy
797
+1
+0.1% +$184 0.08% 110
2024
Q3 		$157K Sell
796
-1
-0.1% -$187 0.1% 108
2024
Q2 		$137K Buy
+797
New +$132K 0.09% 108

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Olistico Wealth's ABBV Position: Q2 2026 in Review

Olistico Wealth increased its AbbVie (ABBV) stake by 96% in Q2 2026, buying an estimated $199K and bringing the position to 1,884 shares worth $474K. The position accounts for 0.2% of the portfolio, ranked #70.

Olistico Wealth first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Olistico Wealth held 1,884 shares of AbbVie worth $474K as of Q2 2026.
  • Olistico Wealth bought 925 AbbVie shares in Q2 2026, an estimated $199K.
  • AbbVie made up 0.2% of Olistico Wealth's portfolio in Q2 2026, its #70 holding.
  • Olistico Wealth first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Olistico Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.